Table 1. Characteristics of the included clinical practice guidelines.
| No | Year | Country/region | Language | Developer | Journal IF (2019) | Topic | Funding source |
|---|---|---|---|---|---|---|---|
| 1, (13) | 2020 | USA | English | AANS, CNS | 3.267 | Glioblastoma | Society |
| 2, (11) | 2020 | Global | English | RAPNO | 33.752 | Pediatric LGG | Unreported |
| 3, (10) | 2020 | Global | English | RAPNO | 33.752 | Pediatric HGG | Unreported |
| 4, (14) | 2020 | Global | English | RAPNO | 33.752 | Pediatric DIPG | Unreported |
| 5, (8) | 2020 | USA | English | AANS, CNS | 3.267 | Glioblastoma | Society |
| 6, (15) | 2020 | USA | English | AANS, CNS | 3.267 | Glioblastoma | Society |
| 7, (16) | 2020 | China | English | CGCG, SNO-China, CBCA | 7.36 | Adult diffuse gliomas | Government |
| 8, (9) | 2020 | USA | English | AANS, CNS | 3.267 | Glioblastoma | Unreported |
| 9, (17) | 2020 | Italy | English | SINch/AINO/SIN | 1.645 | LGG | Unreported |
| 10, (18) | 2020 | USA | English | NCCN | Website | Grade III Glioma | Unreported |
| 11, (19) | 2019 | South Korea | English | KSNO | None | Grade II Gliomas | Unreported |
| 12, (20) | 2019 | South Korea | English | KSNO | None | Pediatric LGG | Unreported |
| 13, (21) | 2019 | Europe | English | SIOP-E-BTG/GPOH | 0.882 | Pediatric LGG | Unreported |
| 14, (22) | 2019 | India | English | ISNO | 2.128 | Adult diffuse gliomas | No funding |
| 15, (23) | 2019 | Europe | English | EANO/EURACAN | 33.752 | Medulloblastoma | Unreported |
| 16, (24) | 2019 | South Korea | English | KSNO | None | Glioblastomas | Unreported |
| 17, (25) | 2018 | USA | English | VHA | None | Diffuse gliomas | Unreported |
| 18, (26) | 2018 | Europe | English | EANO | 10.247 | Ependymal tumors | No funding |
| 19, (27) | 2018 | China | Chinese | NHC | Chinese | Gliomas | Unreported |
| 20, (28) | 2018 | China | Chinese | CGCG | Chinese | Gliomas | Government |
AANS, American Association of Neurological Surgeons; AINO, Italian Association of Neuro-Oncology; BGC-CMDA, Brain Glioma Committee-Chinese Medical Doctor Association; CBCA, Chinese Brain Cancer Association; CGCG, committee of Chinese Glioma Cooperative Group; CNS, the Congress of Neurological Surgeons; DIPG, Diffuse intrinsic pontine glioma; EANO, European Association of Neuro-Oncology; EURACAN, EUropean RAre CANcer; GPOH, society of pediatric oncology and hematology; ISNO, Indian Society of Neuro-oncology; KSNO, Korean Society for Neuro-Oncology; LGG, low-grade glioma; HGG, high-grade glioma; NHC, National Health Commission of the People’s Republic of China; RAPNO, the Response Assessment in Pediatric Neuro-Oncology; SIN, Italian Association of Neurology; SINch, (Italian Society of Neurosurgery) Neuro-Oncology section; SIOP-E-BTG, International Society of Pediatric Oncology-Europe-brain tumor group; SNO-China, Society for Neuro- Oncology of China; VHA, Veterans Health Administration.